HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist
  • 34.900
  • -0.050-0.14%
Market Closed Apr 26 16:08 CST
9.76BMarket Cap-24612P/E (TTM)

KEYMED BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KEYMED BIO-B Earnings Date

Currency: CNY

Period

FY2023 Annual Report

Mar 26, 2024

Revenue(YoY)

354.10M

+253.87%
EPS(YoY)

-1.37

-17.76%
Analyst Rating

Strong Buy

Apr 27, 2024

KEYMED BIO-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 573.193M--
--2024/FY-- / 114.601M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--
Mar 29, 20222021/FY110.269M / 80.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 573.193M--
--2024/FY-- / 114.601M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--
Mar 29, 20222021/FY110.269M / 80.000M--

KEYMED BIO-B Earnings Reports

  • KEYMED BIO-B: 2023 ANNUAL REPORT

    Apr 24 04:30 ET

  • KEYMED BIO-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY

    Mar 26 09:39 ET

  • KEYMED BIO-B: DATE OF BOARD MEETING

    Mar 14 04:31 ET

  • KEYMED BIO-B: 2023 INTERIM REPORT

    Sep 19, 2023 08:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 27, 2024

    Strong Buy

    • Strong Buy

      86.67%

    • Buy

      13.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg